Hospitals’ flat revenues are clashing with rising costs and excessive reimbursement denials from payers, said Rod Hanners, CEO of Keck Medicine of USC. He warned that policy efforts focused solely on limiting provider payments ignore the larger issue of unchecked profits among payers, drugmakers and other healthcare industry players.
NeOnc Technologies is preparing to go public via the less common path of a direct listing as it continues mid-stage testing of its intranasally administered brain cancer drug. Meanwhile, the mostly stagnant biotech IPO pipeline is showing new signs of life with two large stock market debuts expected this week.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The company, which was part of the first Cedars-Sinai accelerator class in 2016, provides a cloud-connected monitoring platform that measures six vital signs and gives doctors actionable insights.
The USC study, released Tuesday, analyzed the prices that 1.6 million people paid for 9.5 million prescriptions in the first half of 2013, based on data from Optum Clinformatics, an organization that sells anonymized claims data for analysis, and National Average Retail Price (NARP) data.
The Virtual Care Clinic will start by offering care in ophthalmology and urology, though plans are one day to include all 1,500 Keck Medicine physicians and researchers.
Wearable and injectable technology, as well as clinical decision support, bring scientific rigor to the project.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
Know the old joke that busy people tell about wishing they could clone themselves? Dr. Leslie Saxon, director of the Center for Body Computing at the University of Southern California is doing that, almost.